Munich - Delayed Quote EUR
SELLAS Life Sciences Group Inc (RXK3.MU)
1.4940
-0.0410
(-2.67%)
At close: May 30 at 5:25:50 PM GMT+2
Loading Chart for RXK3.MU
- Previous Close
1.5350 - Open
1.5310 - Bid 1.4840 x --
- Ask 1.5200 x --
- Day's Range
1.4940 - 1.5310 - 52 Week Range
0.8065 - 1.8500 - Volume
0 - Avg. Volume
12 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 14, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: RXK3.MU
View MorePerformance Overview: RXK3.MU
Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
RXK3.MU
62.57%
S&P 500 (^GSPC)
0.51%
1-Year Return
RXK3.MU
23.47%
S&P 500 (^GSPC)
12.92%
3-Year Return
RXK3.MU
45.21%
S&P 500 (^GSPC)
42.17%
5-Year Return
RXK3.MU
77.36%
S&P 500 (^GSPC)
94.19%
Compare To: RXK3.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RXK3.MU
View MoreValuation Measures
As of 5/30/2025
Market Cap
149.53M
Enterprise Value
125.34M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
6.28
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--